期刊文献+

USG和增强CT对甲状腺癌与中央区淋巴结转移的研究 被引量:4

Study of ultrasonography and contrast-enhanced computer tomography in the diagnosis of thyroid carcinoma and lymph node metastasis
原文传递
导出
摘要 目的评价USG和增强CT对甲状腺癌和中央区淋巴结转移的诊断价值。方法回顾性分析首都医科大学附属北京友谊医院2009年11月-2011年11月收治的73例甲状腺癌患者临床资料。73例患者术前均行USG和增强CT检查,均行甲状腺癌根治术,包含中央区淋巴结清扫,对比术后病理结果。结果USG和增强CT诊断结果与病理结果进行对比分析。USG诊断甲状腺癌的准确率为69.9%,增强CT为80.8%,两者差异无统计学意义(P=0.077)。USG诊断中央区颈部淋巴结转移的准确率为61.6%,阳性预测率为64.0%,阴性预测率为60.4%;增强CT诊断中央区颈部淋巴结转移的准确率为67.1%,阳性预测率为61.7%,阴性预测率为76.9%。2种检查方法差异均无统计学意义(P=0.848,P=0.152,P=0.489)。结论USG与增强CT检查对定性诊断甲状腺癌及评估中央区颈部淋巴结转移差异无统计学意义。 Objective To evaluate the diagnostic value of uhrasonography (USG) and contrast-enhanced computer tomography (CT) for thyroid carcinoma. Methods The results of the review of the preoperative CT and those of the original US reports were compared with the histopathologic results in 73 cases of thyroid carcinoma who underwent radical operation and central compartment dissection from November 2009 to November 2011. Results The final diagnostic rate of thyroid carcinoma with USG was 69.9% , CT of that was 80.8%. There were no significant difference between them ( P = 0. 077). The diagnostic rate of metastatic lymph node in the central compartment with USG was 61.6% , positive predictive value was 64. 0% ,negative predictive value was 60.4%. The diagnostic rate of metastatic lymph node in the central compartment with CT was 67. 1%, positive predictive value was 61.7%, negative predictive value was 76. 9%. There were not significant difference between them(P = 0.848, P = 0. 152, P = 0.489). Conclusion There was no significant difference between USG and CT in The final diagnostic rate of thyroid carcinoma and its lymph node metastasis in the central compartment.
出处 《国际外科学杂志》 2012年第2期87-90,共4页 International Journal of Surgery
关键词 甲状腺癌 淋巴转移 超声检查 增强CT Thyroid cancer Lymphatic metastasis Uhrasonography contrast-enhanced computer tomography
  • 相关文献

参考文献15

  • 1Marshall CL, Lee JE, Xing Y, et al. Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence[J]. Surgery, 2009, 146(6) : 1063-1072.
  • 2Chow SM, Law SC, Chan JK, et al. Papillary microcarcinoma of the thyroid--Prognostic significance of lymph node metastasis and multifocality [J]. Cancer, 2003, 98 ( 1 ) : 31-40.
  • 3Mazzaferri EL. A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine [J]. J Clin Endocrinol Metab, 2009, 94(4) : 1086-1088.
  • 4Caron NR, Tan YY, Ogilvie JB, et al. Selective modified radical neck dissection for papillary thyroid canceris level I, II and V dissection always necessary[ J]. World J Surg, 2006, 30 (5) : 833-840.
  • 5Cheah WK, Arici C, huarte PH , et al. Complications of neck dissection for thyroid cancer [J]. World J Surg, 2002, 26 (8) : 1013-1016.
  • 6Yoon JH, Kim JY, Moon HJ, et al. Contribution of computed tomography to ultrasound in predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma[ J]. Ann Surg Oncol, 2011, 18(6) : 1734-1741.
  • 7van den Breke MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis : assessment of radiologic criteria [ J ]. Radiology, 1990, 177(2) : 379-384.
  • 8American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[ J ]. Thyroid, 2009, 19 ( 11 ) : 1167-1214.
  • 9King AD, Tse GMK, Ahuja AT , et al. Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US radiology[J]. Radiology, 2004, 230(3): 720-726.
  • 10Stulak JM, Grant CS, Farley DR, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer[J]. Arch Surg, 141 (5) : 489-494. discussion : 494-496.

二级参考文献16

  • 1关玉宝,曾庆思,伍筱梅,周良平,彭卫军,谢念危.螺旋CT与高频超声诊断甲状腺癌价值的对比研究[J].中国医学影像学杂志,2005,13(2):136-138. 被引量:16
  • 2魏芳,彭娴婧,许俊,鲍晓峰.甲状腺微小癌的高频超声诊断[J].实用肿瘤杂志,2005,20(3):234-236. 被引量:23
  • 3龙斌,肖必文,王立平.104例甲状腺癌核素显像与超声表现对比研究[J].实用肿瘤杂志,2006,21(6):546-548. 被引量:9
  • 4Nariko O, MegumiM, Kazue O, et al. Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto's thyroiditis[J]. Intern Med, 2007, 46 (9) : 547-550.
  • 5Ishigki S, Shimamoto K, Satake H, et al. Multi-slice CT of thyroid nodules comparison with ultrasonograpy[J]. Radiat Med, 2004,22 (4) : 346-353.
  • 6Senchenkov A,Staren ED. Ultrasound in head and neck surgery: thyroid, parathyroid, and cervical lymph nodes [J]. Surg Clin North Am,2004,84(4):973-1 000.
  • 7Shimura H, Haraguchi K, Hiejima Y,et al. Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma : amulticenterstudy [J]. Thyroid, 2005,15(3) : 251-258.
  • 8Iannuocill JD, Cronan JJ, Monchik JM. Risk for malignancy ofthyroid nodules as assessed by sonographic criteria: the need for biopsy [J]. Ultrasound Med, 2004,23(1):1 455-1 464.
  • 9Silvermen PM, Newman GE, korobkin M, et al. Compated tomography in the evaluation of thyroid disease [ J ]. Am J Roentgenol, 1984,141 (5) : 897 - 902.
  • 10Takashima S, Moriumoto S, Ikezoe J, et al. CT evaluation of anaplastic thyroid carcinoma [ J ], Am J Neuroradiol, 1990,11 (2) :361 -367.

共引文献28

同被引文献38

  • 1Mazzaferri EL. Kloos RT. Clinical review 128: current approa- ches to primary therapy for papillary and follicular thyroid cancer l J ]. J Clin Endocrinol Metab, 2001, 86(4): 1447-1463.
  • 2Lee JW, Yoon DY, Choi CS, et al. Anaplastic thyroid carci- noma: computed tomographic differentiation from other thyroid masses [J 1. Acta Radiol, 2008, 49(3): 321-327.
  • 3Roh JL, Kim JM, Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocal- cemia [J]. Ann SurgOncol, 2011, 18(5): 1312-1318.
  • 4Cooper DS, Doherty GM, Haugen BR, et al. American thyroid association (ATA) guidelines taskforce on thyroid nodules and diff- erentiated thyroid cancer. Revised American thyroid association mana- gement guidelines for patients with thyroid nodules and differentiated thyroid cancer [ J ]. Thyroid, 2009, 19(11): 1167-1214.
  • 5Vergez S, Sarini J, Percodani J, et al. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma [Jl. Eur J Surg Oncol, 2010, 36(8): 777-782.
  • 6Xiao GZ, Gao L. Central lymph node metastasis: is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma ? [J]. World J Surg, 2010, 34(2): 237-241.
  • 7Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection [J]. Ann Surg Oncol, 2008, 15(4): 1177-1182.
  • 8Lupi C, Giannini R, Ugolini C, et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma [J]. J Clin Endo- crinol Metab, 2007, 92(11): 4085-4090.
  • 9Xing M. Prognostic utility of BRAF mutation in papillary thyroid cancer [J]. Mol Cell Endocrinol, 2010, 321(1): 86-93.
  • 10Krishnan J, Kirkin V, Steffen A, et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metas- tasis in immunocompetent rats [J]. Cancer Res, 2003, 63(3): 713-722.

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部